Literature DB >> 6416510

Comparison of human versus porcine insulin in treatment of diabetes in children.

S A Greene, M A Smith, B Cartwright, J D Baum.   

Abstract

The blood glucose control obtained when using semi-synthetic monocomponent human insulin (insulin A) was compared with that using standard monocomponent porcine insulin (insulin B) in 14 children in a double blind crossover study. At the start of the study age, duration of diabetes, insulin dose, and daily carbohydrate intake were the same in both groups. After a one month run in period of standard treatment with porcine insulin the children were randomly divided into group 1 (three months of insulin A followed by three months of insulin B) and group 2 (three months of insulin B followed by three months of insulin A). During each treatment period blood glucose control was assessed by clinical symptoms, glycosylated haemoglobin, and home blood glucose monitoring. Although a significant difference in the period after lunch during 24 hour blood glucose profiles suggested a shorter onset time and faster peak action time of human insulin, no significant difference in the overall diabetic control was seen between the two types of insulin. There was a trend towards improved blood glucose control (irrespective of insulin) as the trial progressed. No clinical reactions to human insulin occurred, and there was no significant difference in the daily insulin dose between porcine and human insulin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416510      PMCID: PMC1549780          DOI: 10.1136/bmj.287.6405.1578

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus.

Authors:  J E Gerich
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

2.  Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients.

Authors:  A J Clark; R O Adeniyi-Jones; G Knight; J M Leiper; P G Wiles; R H Jones; H Keen; A C MacCuish; J D Ward; P J Watkins; J M Cauldwell; A Glynne; J B Scotton
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

3.  Chemical, physical, and biologic properties of biosynthetic human insulin.

Authors:  R E Chance; E P Kroeff; J A Hoffmann; B H Frank
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

  3 in total
  6 in total

Review 1.  Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus.

Authors:  K Zuppinger; C Aebi; S Fankhauser; G Herz; R P Zurbrügg; K Schopfer; T M Neri
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

3.  Developing a Rapid Algorithm to Enable Rapid Characterization of Alginate Microcapsules.

Authors:  Ka Hei Chan; Rahul Krishnan; Michael Alexander; Jonathan R T Lakey
Journal:  Cell Transplant       Date:  2016-10-10       Impact factor: 4.064

4.  Management of secondary diabetes mellitus after total pancreatectomy in infancy.

Authors:  S A Greene; A Aynsley-Green; G Soltesz; J D Baum
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

5.  Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin.

Authors:  A S Luyckx; J C Daubresse; C Jaminet; A Scheen; P J Lefebvre
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

6.  Metabolic rhythms in adolescents with diabetes during treatment with porcine or human insulin.

Authors:  M D Hocking; J Crase; P H Rayner; M Nattrass
Journal:  Arch Dis Child       Date:  1986-04       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.